IL107323A0 - 5-(n-heterosubstituted amino) quinolones and pharmaceutical compositions containing them - Google Patents

5-(n-heterosubstituted amino) quinolones and pharmaceutical compositions containing them

Info

Publication number
IL107323A0
IL107323A0 IL107323A IL10732393A IL107323A0 IL 107323 A0 IL107323 A0 IL 107323A0 IL 107323 A IL107323 A IL 107323A IL 10732393 A IL10732393 A IL 10732393A IL 107323 A0 IL107323 A0 IL 107323A0
Authority
IL
Israel
Prior art keywords
quinolones
pharmaceutical compositions
compositions containing
heterosubstituted amino
heterosubstituted
Prior art date
Application number
IL107323A
Other versions
IL107323A (en
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL107323A0 publication Critical patent/IL107323A0/en
Publication of IL107323A publication Critical patent/IL107323A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL10732393A 1992-10-30 1993-10-19 Pharmaceutical compositions containing 5-(N-heterosubstituted amino) quinolones and several such new compounds IL107323A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30

Publications (2)

Publication Number Publication Date
IL107323A0 true IL107323A0 (en) 1994-01-25
IL107323A IL107323A (en) 2000-06-01

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10732393A IL107323A (en) 1992-10-30 1993-10-19 Pharmaceutical compositions containing 5-(N-heterosubstituted amino) quinolones and several such new compounds

Country Status (21)

Country Link
EP (1) EP0666853A1 (en)
JP (1) JPH08502750A (en)
KR (1) KR950704301A (en)
CN (1) CN1064357C (en)
AU (1) AU687018B2 (en)
BR (1) BR9307347A (en)
CA (1) CA2148003A1 (en)
CZ (1) CZ282581B6 (en)
EG (1) EG20543A (en)
FI (1) FI952049A (en)
HU (1) HUT72072A (en)
IL (1) IL107323A (en)
MX (1) MX9306814A (en)
NO (1) NO951640L (en)
NZ (1) NZ257470A (en)
PL (1) PL178094B1 (en)
RU (1) RU2126000C1 (en)
SG (1) SG59979A1 (en)
SK (1) SK54795A3 (en)
WO (1) WO1994010163A1 (en)
ZA (1) ZA938089B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
ATE190972T1 (en) * 1994-08-02 2000-04-15 Procter & Gamble METHOD FOR PRODUCING ANTIMICROBIAL COMPOUNDS
EP0775145A1 (en) * 1994-08-02 1997-05-28 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
CA2242242C (en) * 1996-02-09 2001-08-07 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT1901749T (en) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones and uses thereof
EE05697B1 (en) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (en) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Quinoline derivatives as antibacterial agents
CN101020647B (en) * 2007-02-14 2011-03-30 杭州师范学院 Synthesis process of beta-cyclopropylamino acrylate
US8063066B2 (en) 2007-03-19 2011-11-22 Takeda Pharmaceutical Company Limited MAPK/ERK kinase inhibitors
DK3092901T3 (en) * 2007-10-05 2020-05-18 Senhwa Biosciences Inc QUINOLON ANALOGS AND PROCEDURES RELATED
MX2010012855A (en) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials.
ES2809177T3 (en) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalation of levofloxacin to reduce lung inflammation
JP2012505223A (en) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド Aerosol fluoroquinolone formulation for improved pharmacokinetics
AR076222A1 (en) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd DERIVATIVES 2-HYDROXIETIL-1H-QUINOLIN-ONA AND ITS AZAISOTHERAL ANALOGS WITH ANTIBACTERIAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (en) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd Novel pyridonecarboxylic acid derivative and salt thereof
DE3906365A1 (en) * 1988-07-15 1990-01-18 Bayer Ag 7- (1-PYRROLIDINYL) -3-CHINOLONE AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES, METHOD AND SUBSTITUTED (OXA) DIAZABICYCLOOCTANES AND NONANESE AS INTERMEDIATE PRODUCTS, AND ANTIBACTERIAL AGENTS AND FOOD ADDITIVES CONTAINING THEM
IE66202B1 (en) * 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
JPH05506033A (en) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド Antimicrobial quinolonyl lactams
WO1992009596A1 (en) * 1990-11-30 1992-06-11 Warner-Lambert Company Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents

Also Published As

Publication number Publication date
MX9306814A (en) 1994-07-29
CA2148003A1 (en) 1994-05-11
ZA938089B (en) 1994-06-07
SK54795A3 (en) 1995-12-06
BR9307347A (en) 1999-05-25
HUT72072A (en) 1996-03-28
PL178094B1 (en) 2000-02-29
NZ257470A (en) 1997-08-22
EG20543A (en) 1999-07-31
KR950704301A (en) 1995-11-17
NO951640D0 (en) 1995-04-28
AU687018B2 (en) 1998-02-19
SG59979A1 (en) 1999-02-22
IL107323A (en) 2000-06-01
FI952049A0 (en) 1995-04-28
RU95110762A (en) 1997-01-10
CN1064357C (en) 2001-04-11
JPH08502750A (en) 1996-03-26
NO951640L (en) 1995-06-30
WO1994010163A1 (en) 1994-05-11
FI952049A (en) 1995-04-28
CN1092773A (en) 1994-09-28
EP0666853A1 (en) 1995-08-16
HU9501237D0 (en) 1995-06-28
RU2126000C1 (en) 1999-02-10
CZ282581B6 (en) 1997-08-13
CZ109795A3 (en) 1995-12-13
AU5409794A (en) 1994-05-24
PL308671A1 (en) 1995-08-21

Similar Documents

Publication Publication Date Title
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL105806A0 (en) Aminoquinoline derivatives and pharmaceutical compositions containing the same
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
IL103910A0 (en) New peptide derivatives and pharmaceutical compositions containing them
IL105220A0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL114622A (en) 5-membered heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL114626A (en) 6-membered nitrogen-containing heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL104824A0 (en) Heterobicyclic compounds and pharmaceutical compositions containing them
IL111785A0 (en) Dp-iv inhibitors and pharmaceutical compositions containing them
IL110743A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
ZA94342B (en) C2 Taxane derivatives and pharmaceutical compositions containing them
NZ314376A (en) Substituted sulphonamides and pharmaceutical compositions
IL105003A0 (en) Indole derivatives and pharmaceutical compositions containing them
IL97737A0 (en) Quinolone thioureas and pharmaceutical compositions containing them
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
IL106553A0 (en) Substituted imidazoles and pharmaceutical compositions containing them
IL109782A0 (en) Imidazole-5-position substituted angiotensin II antagonists and pharmaceutical compositions containing them
IL107323A0 (en) 5-(n-heterosubstituted amino) quinolones and pharmaceutical compositions containing them
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL107177A0 (en) 1-Substituted oxindoles and azaoxindoles and pharmaceutical compositions comprising them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL110033A0 (en) Bis-imide derivatives and pharmaceutical compositions containing them
IL114955A (en) N-substituted naphthofused lactams and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force